Antibody-Dependent Cellular Phagocytosis and Its Impact on Pathogen Control

Antibody Fc: Linking Adaptive and Innate Immunity

Volumn , Issue , 2013, Pages 29-47

  Weber, Stefan S ^a   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Antibody; Bacterium; Fc receptor; Fungus; Opsonization; Parasite; Pathogen control; Phagocyte; Phagocytosis; Virus

Indexed keywords

EID: 84902427309     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-394802-1.00002-9     Document Type: Chapter

References (169)

1. Ravetch JV, Nimmerjahn F Fc Receptors and their role in immune regulation and inflammation. Fundamental Immunology 2008, 684-707. Lippincott Williams & Wilkins, Philadelphia PA. 6th ed. W.E. Paul (Ed.).
2. Nimmerjahn F, Ravetch JV Fcγ receptors as regulators of immune responses. Nat Rev Immunol 2008, 8(1):34-47.
3. Mancardi DA, Iannascoli B, Hoos S, England P, Daeron M, Bruhns P FcγRIV is a mouse IgE receptor that resembles macrophage FcεRI in humans and promotes IgE-induced lung inflammation. J Clin Invest 2008, 118(11):3738-3750.
4. Li M, Wirthmueller U, Ravetch JV Reconstitution of human FcγRIII cell type specificity in transgenic mice. J Exp Med 1996, 183(3):1259-1263.
5. Bonnerot C, Amigorena S, Choquet D, Pavlovich R, Choukroun V, Fridman WH Role of associated γ-chain in tyrosine kinase activation via murine FcγRIII. EMBO J 1992, 11(7):2747-2757.
6. Indik ZK, Hunter S, Huang MM, Pan XQ, Chien P, Kelly C, et al. The high affinity Fcγ receptor (CD64) induces phagocytosis in the absence of its cytoplasmic domain: the γ subunit of Fcγ RIIIA imparts phagocytic function to Fcγ RI. Exp Hematol 1994, 22(7):599-606.
7. Nimmerjahn F, Ravetch JV Fcγ receptors: old friends and new family members. Immunity 2006, 24(1):19-28.
8. Pan XQ, Darby C, Indik ZK, Schreiber AD Activation of three classes of nonreceptor tyrosine kinases following Fcγ receptor crosslinking in human monocytes. Clin Immunol 1999, 90(1):55-64.
9. Biburger M, Aschermann S, Schwab I, Lux A, Albert H, Danzer H, et al. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo. Immunity 2011, 35(6):932-944.
10. Berger M, Norvell TM, Tosi MF, Emancipator SN, Konstan MW, Schreiber JR Tissue-specific Fcγ and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr Res 1994, 35(1):68-77.
11. Serezani CH, Aronoff DM, Sitrin RG, Peters-Golden M FcγRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions. Blood 2009, 114(15):3316-3324.
12. Meknache N, Jonsson F, Laurent J, Guinnepain MT, Daeron M Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcγRIIIB (CD16B). J Immunol 2009, 182(4):2542-2550.
13. Edberg JC, Kimberly RP Modulation of Fcγ and complement receptor function by the glycosyl-phosphatidylinositol-anchored form of FcγRIII. J Immunol 1994, 152(12):5826-5835.
14. Marois L, Pare G, Vaillancourt M, Rollet-Labelle E, Naccache PH FcγRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. J Biol Chem 2011, 286(5):3509-3519.
15. Petroni KC, Shen L, Guyre PM Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-γ and glucocorticoids. J Immunol 1988, 140(10):3467-3472.
16. Rivas-Fuentes S, Garcia-Garcia E, Nieto-Castaneda G, Rosales C Fcγ receptors exhibit different phagocytosis potential in human neutrophils. Cell Immunol 2010, 263(1):114-121.
17. Marois L, Vaillancourt M, Marois S, Proulx S, Pare G, Rollet-Labelle E, et al. The ubiquitin ligase c-Cbl down-regulates FcγRIIa activation in human neutrophils. J Immunol 2009, 182(4):2374-2384.
18. Vidarsson G, Stemerding AM, Stapleton NM, Spliethoff SE, Janssen H, Rebers FE, et al. FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006, 108(10):3573-3579.
19. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M, et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999, 189(2):371-380.
20. Rafiq K, Bergtold A, Clynes R Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest 2002, 110(1):71-79.
21. Pearse RN, Feinman R, Ravetch JV Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by γ-interferon is mediated through common DNA response elements. Proc Nat Acad Sci USA 1991, 88(24):11305-11309.
22. Quan Y, Möller T, Weinstein JR Regulation of Fcγ receptors and immunoglobulin G-mediated phagocytosis in mouse microglia. Neurosci Lett 2009, 464(1):29-33.
23. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RA, et al. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Nat Acad Sci USA 2010, 107(9):4287-4292.
24. Flannagan RS, Harrison RE, Yip CM, Jaqaman K, Grinstein S Dynamic macrophage "probing" is required for the efficient capture of phagocytic targets. J Cell Biol 2010, 191(6):1205-1218.
25. Zhang Y, Hoppe AD, Swanson JA Coordination of Fc receptor signaling regulates cellular commitment to phagocytosis. Proc Nat Acad Sci USA 2010, 107(45):19332-19337.
26. Nagashima H, Ootsubo M, Fukazawa M, Motoi S, Konakahara S, Masuho Y Enhanced antibody-dependent cellular phagocytosis by chimeric monoclonal antibodies with tandemly repeated Fc domains. J Biosci Bioeng 2011, 111(4):391-396.
27. Garcia-Garcia E, Rosales C Signal transduction during Fc receptor-mediated phagocytosis. J Leukocyte Biol 2002, 72(6):1092-1108.
28. Swanson JA, Hoppe AD The coordination of signaling during Fc receptor-mediated phagocytosis. J Leukocyte Biol 2004, 76(6):1093-1103.
29. Wang AV, Scholl PR, Geha RS Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn. J Exp Med 1994, 180(3):1165-1170.
30. Sobota A, Strzelecka-Kiliszek A, Gladkowska E, Yoshida K, Mrozinska K, Kwiatkowska K Binding of IgG-opsonized particles to FcγR is an active stage of phagocytosis that involves receptor clustering and phosphorylation. J Immunol 2005, 175(7):4450-4457.
31. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, et al. A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages. J Exp Med 1997, 186(7):1027-1039.
32. Cooney DS, Phee H, Jacob A, Coggeshall KM Signal transduction by human-restricted FcγRIIa involves three distinct cytoplasmic kinase families leading to phagocytosis. J Immunol 2001, 167(2):844-854.
33. MAPK in Fc gamma receptor-stimulated TNF-α synthesis. J Immunol 1997, 158(7):3433-3438.
34. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, et al. Cross-linking of Fcγ receptor I (FcγRI) and receptor II (FcγRII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J Biol Chem 1993, 268(32):24442-24448.
35. Darby C, Geahlen RL, Schreiber AD Stimulation of macrophage FcγRIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein. J Immunol 1994, 152(11):5429-5437.
36. Araki N, Johnson MT, Swanson JA A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996, 135(5):1249-1260.
37. Garcia-Garcia E, Rosales R, Rosales C Phosphatidylinositol 3-kinase and extracellular signal-regulated kinase are recruited for Fc receptor-mediated phagocytosis during monocyte-to-macrophage differentiation. J Leukocyte Biol 2002, 72(1):107-114.
38. Saito K, Scharenberg AM, Kinet JP Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J Biol Chem 2001, 276(19):16201-16206.
39. Jongstra-Bilen J, Puig Cano A, Hasija M, Xiao H, Smith CI, Cybulsky MI Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcγ receptor-induced signaling and phagocytosis. J Immunol 2008, 181(1):288-298.
40. Massol P, Montcourrier P, Guillemot JC, Chavrier P Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J 1998, 17(21):6219-6229.
41. Castellano F, Montcourrier P, Chavrier P Membrane recruitment of Rac1 triggers phagocytosis. J Cell Sci 2000, 113(Pt 17):2955-2961.
42. Castellano F, Montcourrier P, Guillemot JC, Gouin E, Machesky L, Cossart P, et al. Inducible recruitment of Cdc42 or WASP to a cell-surface receptor triggers actin polymerization and filopodium formation. Curr Biol 1999, 9(7):351-360.
43. Zhang Q, Cox D, Tseng CC, Donaldson JG, Greenberg S A requirement for ARF6 in Fcγ receptor-mediated phagocytosis in macrophages. J Biol Chem 1998, 273(32):19977-19981.
44. Venkateswarlu K, Cullen PJ Signalling via ADP-ribosylation factor 6 lies downstream of phosphatidylinositide 3-kinase. Biochem J 2000, 345(Pt 3):719-724.
45. Liao F, Shin HS, Rhee SG Tyrosine phosphorylation of phospholipase C-γ 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells. Proc Nat Acad Sci USA 1992, 89(8):3659-3663.
46. Zheleznyak A, Brown EJ Immunoglobulin-mediated phagocytosis by human monocytes requires protein kinase C activation. Evidence for protein kinase C translocation to phagosomes. J Biol Chem 1992, 267(17):12042-12048.
47. Breton A, Descoteaux A Protein kinase C-α participates in FcγR-mediated phagocytosis in macrophages. Biochem Biophys Res Commun 2000, 276(2):472-476.
48. Larsen EC, DiGennaro JA, Saito N, Mehta S, Loegering DJ, Mazurkiewicz JE, et al. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol 2000, 165(5):2809-2817.
49. Anderson CL, Guyre PM, Whitin JC, Ryan DH, Looney RJ, Fanger MW Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem 1986, 261(27):12856-12864.
50. Pfefferkorn LC, Fanger MW Cross-linking of the high affinity Fc receptor for human immunoglobulin G1 triggers transient activation of NADPH oxidase activity. Continuous oxidase activation requires continuous de novo receptor cross-linking. J Biol Chem 1989, 264(24):14112-14120.
51. Nobes CD, Hall A Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81(1):53-62.
52. Caron E, Hall A Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998, 282(5394):1717-1721.
53. Hall AB, Gakidis MA, Glogauer M, Wilsbacher JL, Gao S, Swat W, et al. Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcγR- and complement-mediated phagocytosis. Immunity 2006, 24(3):305-316.
54. Anderson KE, Chessa TA, Davidson K, Henderson RB, Walker S, Tolmachova T, et al. PtdIns3P and Rac direct the assembly of the NADPH oxidase on a novel, pre-phagosomal compartment during FcR-mediated phagocytosis in primary mouse neutrophils. Blood 2010, 116(23):4978-4989.
55. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JVA 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 1994, 368(6466):70-73.
56. Ono M, Bolland S, Tempst P, Ravetch JV Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 1996, 383(6597):263-266.
57. Bolland S, Pearse RN, Kurosaki T, Ravetch JV SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998, 8(4):509-516.
58. Baerenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp G, et al. Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. Proc Nat Acad Sci USA 2011, 108(46):18772-18777.
59. Hazeki K, Inoue K, Nigorikawa K, Hazeki O Negative regulation of class IA phosphoinositide 3-kinase by protein kinase Cδ limits Fcγ receptor-mediated phagocytosis in macrophages. J Biochem 2009, 145(1):87-94.
60. Kinchen JM, Ravichandran KS Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol 2008, 9(10):781-795.
61. Ellson CD, Anderson KE, Morgan G, Chilvers ER, Lipp P, Stephens LR, et al. Phosphatidylinositol 3-phosphate is generated in phagosomal membranes. Curr Biol 2001, 11(20):1631-1635.
62. Vieira OV, Botelho RJ, Rameh L, Brachmann SM, Matsuo T, Davidson HW, et al. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol 2001, 155(1):19-25.
63. phox phosphatidylinositol 3-phosphate (PI(3)P) binding. J Biol Chem 2011, 286(47):40693-40705.
64. Trivedi V, Zhang SC, Castoreno AB, Stockinger W, Shieh EC, Vyas JM, et al. Immunoglobulin G signaling activates lysosome/phagosome docking. Proc Nat Acad Sci USA 2006, 103(48):18226-18231.
65. Worth RG, Mayo-Bond L, Kim MK, van de Winkel JG, Todd RF, Petty HR, et al. The cytoplasmic domain of FcγRIIA (CD32) participates in phagolysosome formation. Blood 2001, 98(12):3429-3434.
66. Worth RG, Kim MK, Kindzelskii AL, Petty HR, Schreiber AD Signal sequence within FcγRIIA controls calcium wave propagation patterns: apparent role in phagolysosome fusion. Proc Nat Acad Sci USA 2003, 100(8):4533-4538.
67. Shibaki A, Ohkawara A, Cooper KD Differential extracellular signaling via FcγR and FMLP in functionally distinct antigen-presenting cell subsets: ultraviolet-induced epidermal macrophages versus Langerhans cells. J Invest Dermatol 1995, 105(3):383-387.
68. Fanger NA, Voigtlaender D, Liu C, Swink S, Wardwell K, Fisher J, et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells. J Immunol 1997, 158(7):3090-3098.
69. Canetti C, Aronoff DM, Choe M, Flamand N, Wettlaufer S, Toews GB, et al. Differential regulation by leukotrienes and calcium of Fcγ receptor-induced phagocytosis and Syk activation in dendritic cells versus macrophages. J Leukocyte Biol 2006, 79(6):1234-1241.
70. Mancuso P, Peters-Golden M Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent. Am J Respir Cell Mol Biol 2000, 23(6):727-733.
71. Campos MR, Serezani CH, Peters-Golden M, Jancar S Differential kinase requirement for enhancement of FcγR-mediated phagocytosis in alveolar macrophages by leukotriene B4 vs. D4. Mol Immunol 2009, 46(6):1204-1211.
72. Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 2002, 70(8):4165-4176.
73. Groves E, Rittinger K, Amstutz M, Berry S, Holden DW, Cornelis GR, et al. Sequestering of Rac by the Yersinia effector YopO blocks Fcγ receptor-mediated phagocytosis. J Biol Chem 2010, 285(6):4087-4098.
74. Fallman M, Gustavsson A Cellular mechanisms of bacterial internalization counteracted by Yersinia. Int Rev Cytol 2005, 246:135-188.
75. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312(5777):1211-1214.
76. Casadevall A, Pirofski LA A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 2006, 91:1-44.
77. Joller N, Weber SS, Oxenius A Antibody-Fc receptor interactions in protection against intracellular pathogens. Eur J Immunol 2011, 41(4):889-897.
78. Rhinehart-Jones TR, Fortier AH, Elkins KL Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host γ interferon and T cells. Infect Immun 1994, 62(8):3129-3137.
79. Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, Schlesinger LS Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 2006, 74(9):5114-5125.
80. Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol 2007, 179(1):532-539.
81. Geier H, Celli J Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun 2011, 79(6):2204-2214.
82. Yang X, Brunham RC Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol 1998, 161(3):1439-1446.
83. Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO, et al. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 2002, 105(2):213-221.
84. Moore T, Ekworomadu CO, Eko FO, MacMillan L, Ramey K, Ananaba GA, et al. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 2003, 188(4):617-624.
85. Tobar JA, Gonzalez PA, Kalergis AM Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fcγ receptors on dendritic cells. J Immunol 2004, 173(6):4058-4065.
86. Herrada AA, Contreras FJ, Tobar JA, Pacheco R, Kalergis AM Immune complex-induced enhancement of bacterial antigen presentation requires Fcγ receptor III expression on dendritic cells. Proc Nat Acad Sci USA 2007, 104(33):13402-13407.
87. Riquelme SA, Bueno SM, Kalergis AM IgG keeps virulent Salmonella from evading dendritic cell uptake. Immunology 2012, 136(3):291-305.
88. Joller N, Weber SS, Müller AJ, Spörri R, Selchow P, Sander P, et al. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Nat Acad Sci USA 2010, 107(47):20441-20446.
89. de Valliere S, Abate G, Blazevic A, Heuertz RM, Hoft DF Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect Immun 2005, 73(10):6711-6720.
90. Armstrong JA, Hart PD Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975, 142(1):1-16.
91. Humphres RC, Hinrichs DJ Role of antibody in Coxiella burnetii infection. Infect Immun 1981, 31(2):641-645.
92. Zhang G, Russell-Lodrigue KE, Andoh M, Zhang Y, Hendrix LR, Samuel JE Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J Immunol 2007, 179(12):8372-8380.
93. Shannon JG, Cockrell DC, Takahashi K, Stahl GL, Heinzen RA Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol 2009, 10:26.
94. Collin M, Olsen A EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001, 20(12):3046-3055.
95. Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, Olsen A EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002, 70(12):6646-6651.
96. Vincents B, von Pawel-Rammingen U, Bjorck L, Abrahamson M Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 2004, 43(49):15540-15549.
97. von Pawel-Rammingen U, Johansson BP, Bjorck L IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002, 21(7):1607-1615.
98. Crane DD, Warner SL, Bosio CM A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis. J Immunol 2009, 183(7):4593-4600.
99. Brezski RJ, Jordan RE Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?. MAbs 2010, 2(3):212-220.
100. Brezski RJ, Luongo JL, Petrone D, Ryan MH, Zhong D, Tam SH, et al. Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs. J Immunol 2008, 181(5):3183-3192.
101. Mittal R, Sukumaran SK, Selvaraj SK, Wooster DG, Babu MM, Schreiber AD, et al. Fcγ receptor I α-chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1. PLoS Pathog 2010, 6(11):e1001203.
102. Burton DR Antibodies, viruses and vaccines. Nat Rev Immunol 2002, 2(9):706-713.
103. Hangartner L, Zinkernagel RM, Hengartner H Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 2006, 6(3):231-243.
104. Reading SA, Dimmock NJ Neutralization of animal virus infectivity by antibody. Arch Virol 2007, 152(6):1047-1059.
105. Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Nat Acad Sci USA 2010, 107(46):19985-19990.
106. Thompson BS, Moesker B, Smit JM, Wilschut J, Diamond MS, Fremont DH A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog 2009, 5(5):e1000453.
107. Imai M, Sugimoto K, Okazaki K, Kida H Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin. Virus Res 1998, 53(2):129-139.
108. Glauser DL, Kratz AS, Gillet L, Stevenson PG A mechanistic basis for potent, glycoprotein B-directed γ-herpesvirus neutralization. J Gen Virol 2011, 92(Pt 9):2020-2033.
109. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 2010, 10(10):712-722.
110. Sun P, Bauza K, Pal S, Liang Z, Wu SJ, Beckett C, et al. Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virology 2011, 421(2):245-252.
111. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328(5979):745-748.
112. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 2011, 85(4):1671-1683.
113. Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, Yeh TM, et al. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol 2006, 176(5):2825-2832.
114. Halstead SB, Venkateshan CN, Gentry MK, Larsen LK Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 1984, 132(3):1529-1532.
115. Halstead SB Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003, 60:421-467.
116. Fust G Enhancing antibodies in HIV infection. Parasitology 1997, 115(Suppl):S127-S140.
117. McKeating JA, Griffiths PD, Weiss RA HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 1990, 343(6259):659-661.
118. Takeda A, Tuazon CU, Ennis FA Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988, 242(4878):580-583.
119. Robinson WE, Montefiori DC, Gillespie DH, Mitchell WM Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. J Acquir Immune Defic Syndr 1989, 2(1):33-42.
120. Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG IgG fc receptors provide an alternative infection route for murine γ-herpesvirus-68. PLoS One 2007, 2(6):e560.
121. Tamura M, Webster RG, Ennis FA Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J Virol 1994, 68(6):3499-3504.
122. Gotoff R, Tamura M, Janus J, Thompson J, Wright P, Ennis FA Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells. J Infect Dis 1994, 169(1):200-203.
123. Tamura M, Webster RG, Ennis FA Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin. J Immunol 1993, 151(3):1731-1738.
124. Ochiai H, Kurokawa M, Matsui S, Yamamoto T, Kuroki Y, Kishimoto C, et al. Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody. J Med Virol 1992, 36(3):217-221.
125. Tamura M, Webster RG, Ennis FA Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 1991, 182(1):211-219.
126. Inada T, Chong KT, Mims CA Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol 1985, 66(Pt 4):871-878.
127. Baxt B, Mason PW Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 1995, 207(2):503-509.
128. Mason PW, Baxt B, Brown F, Harber J, Murdin A, Wimmer E Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 1993, 192(2):568-577.
129. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol 2006, 80(17):8530-8540.
130. Kishimoto C, Kurokawa M, Ochiai H Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J Mol Cell Cardiol 2002, 34(9):1227-1238.
131. Mahalingam S, Lidbury BA Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κB) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc Nat Acad Sci USA 2002, 99(21):13819-13824.
132. Bloom ME, Best SM, Hayes SF, Wells RD, Wolfinbarger JB, McKenna R, et al. Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation. J Virol 2001, 75(22):11116-11127.
133. McMichael AJ, Haynes BF Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat Immunol 2012, 13(5):423-427.
134. Forthal DN, Gilbert PB, Landucci G, Phan T Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 2007, 178(10):6596-6603.
135. Holl V, Hemmerter S, Burrer R, Schmidt S, Bohbot A, Aubertin AM, et al. Involvement of FcγRI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J Immunol 2004, 173(10):6274-6283.
136. Perez-Bercoff D, David A, Sudry H, Barre-Sinoussi F, Pancino G Fcγ receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 2003, 77(7):4081-4094.
137. Bai Y, Ye L, Tesar DB, Song H, Zhao D, Bjorkman PJ, et al. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Nat Acad Sci USA 2011, 108(45):18406-18411.
138. Mazanec MB, Coudret CL, Fletcher DR Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995, 69(2):1339-1343.
139. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Peterra J, Nedrud JG Intracellular neutralization of Sendai and influenza viruses by IgA monoclonal antibodies. Adv Exp Med Biol 1995, 371A:651-654.
140. Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 2001, 166(12):7381-7388.
141. El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A, et al. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol 2011, 186(2):1022-1031.
142. Sutterwala FS, Noel GJ, Salgame P, Mosser DM Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J Exp Med 1998, 188(1):217-222.
143. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999, 59(3):329-334.
144. Zaiss AK, Vilaysane A, Cotter MJ, Clark SA, Meijndert HC, Colarusso P, et al. Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response. J Immunol 2009, 182(11):7058-7068.
145. Guy RA, Belosevic M Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect Immun 1993, 61(4):1553-1558.
146. Peters C, Aebischer T, Stierhof YD, Fuchs M, Overath P The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J Cell Sci 1995, 108(Pt 12):3715-3724.
147. Mosser DM Receptors on phagocytic cells involved in microbial recognition. Immunol Ser 1994, 60:99-114.
148. Dasgupta D, Chakraborty P, Basu MK Ligation of Fc receptor of macrophages stimulates protein kinase C and anti-leishmanial activity. Mol Cell Biochem 2000, 209(1-2):1-8.
149. Padigel UM, Farrell JP Control of infection with Leishmania major in susceptible BALB/c mice lacking the common γ-chain for FcR is associated with reduced production of IL-10 and TGF-β by parasitized cells. J Immunol 2005, 174(10):6340-6345.
150. Kane MM, Mosser DM The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 2001, 166(2):1141-1147.
151. Buxbaum LU A detrimental role for IgG and FcγR in Leishmania mexicana infection. Immunol Res 2008, 42(1-3):197-209.
152. Thomas BN, Buxbaum LU FcγRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Infect Immun 2008, 76(2):623-631.
153. Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, Verbeek S, et al. Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. J Exp Med 2006, 203(1):177-188.
154. Sibley LD, Weidner E, Krahenbuhl JL Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 1985, 315(6018):416-419.
155. Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science 1990, 249(4969):641-646.
156. Anderson SE, Bautista SC, Remington JS Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages. Clin Exp Immunol 1976, 26(3):375-380.
157. Erbe DV, Pfefferkorn ER, Fanger MW Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. J Immunol 1991, 146(9):3145-3151.
158. Fadul CE, Channon JY, Kasper LH Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect Immun 1995, 63(11):4290-4294.
159. Kang H, Remington JS, Suzuki Y Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J Immunol 2000, 164(5):2629-2634.
160. van Spriel AB, van den Herik-Oudijk IE, van Sorge NM, Vile HA, van Strijp JA, van de Winkel JG Effective phagocytosis and killing of Candida albicans via targeting FcγRI (CD64) or FcαRI (CD89) on neutrophils. J Infect Dis 1999, 179(3):661-669.
161. Cutler JE, Deepe GS, Klein BS Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 2007, 5(1):13-28.
162. Bromuro C, Torosantucci A, Chiani P, Conti S, Polonelli L, Cassone A Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect Immun 2002, 70(10):5462-5470.
163. Torosantucci A, Chiani P, Bromuro C, De Bernardis F, Palma AS, Liu Y, et al. Protection by anti-β-glucan antibodies is associated with restricted β-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 2009, 4(4):e5392.
164. Hu Y, Farah CS, Ashman RB Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses. Microbes Infect 2006, 8(3):612-620.
165. Yuan R, Casadevall A, Spira G, Scharff MD Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol 1995, 154(4):1810-1816.
166. Yuan RR, Casadevall A, Oh J, Scharff MD T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Nat Acad Sci USA 1997, 94(6):2483-2488.
167. Mukherjee S, Lee SC, Casadevall A Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995, 63(2):573-579.
168. Yuan R, Clynes R, Oh J, Ravetch JV, Scharff MD Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 1998, 187(4):641-648.
169. van Sorge NM, van der Pol WL, van de Winkel JG FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003, 61(3):189-202.